Wednesday, March 18, 2026

8 Hospitals in Busan Under Fire for Illegally Prescribing Appetite Suppressants: What You Need to Know

Doctors from eight hospitals and 35 patients have been apprehended by Busan police on a large scale for drug law violations involving the misuse and abuse of prescription appetite suppressants,which are psychoactive drugs circulated for diet purposes.

On Thursday, the Busan Police Agency announced that nine doctors and 26 patients from eight hospitals and clinics were charged without detention for violating the Narcotics Control Act.

The investigation revealed that between January 2023 and October 2024, doctors allegedly prescribed appetite suppressants, classified as psychoactive drugs, for non-medical purposes. Patients are accused of consuming these medications during the same period.

The Ministry of Food and Drug Safety guidelines stipulate that appetite suppressants should only be prescribed to patients with an initial body mass index (BMI) of 30 kg/m² or higher. Furthermore, the total prescription duration must not exceed three months, and they should not be combined with other psychoactive medications or given to patients under 16.

Police initiated the investigation following tips about the improper prescription of controlled substances for non-medical reasons.

One doctor, identified as Dr. B from Medical Institution A, allegedly failed to document clear diagnoses and prescribed appetite suppressants long-term using the same pattern. In another case, Patient C requested and received appetite suppressants for cosmetic purposes despite having a normal BMI, leading to prolonged abuse.

During questioning, one arrested doctor attempted to justify his actions, stating, “Patients requested appetite suppressants to lose weight. How could I refuse when they kept asking?”

A police spokesperson emphasized, “Appetite suppressants are classified as medical narcotics. We aim to increase awareness about the dangers of improper prescription and ensure safer medical environments for citizens. These drugs should only be cautiously prescribed to patients who genuinely need obesity treatment, as excessive use can lead to mood disorders and addiction.”

Hot this week

Unlocking the Power of Intel Core Series 2: A Comprehensive Guide to Edge AI Solutions

Intel unveils Core Processor Series 2 and AI suite for healthcare, enhancing edge computing performance and reliability in industrial settings.

Samsung’s Record R&D Investment: How it is Shaping the Future of AI and Semiconductors

Samsung Electronics invested a record $25.33 billion in R&D to lead in AI and semiconductors, boosting its future tech capabilities.

How Rising Fuel Prices Impact Asian Airlines: A Comparison of FSC vs. LCC

Low-cost carriers are struggling to cope with rising fuel prices, lacking effective hedging strategies unlike major airlines.

SK Group Invests 630 Million USD AI Company

SK Group invests heavily in AI, aiming to transform into a leader in the AI market through a new U.S. investment firm.

Nvidia’s Jensen Huang Predicts 1000x Surge in AI Computing Demand

Nvidia's CEO highlights surging AI computing demand due to AI agents like OpenClaw, boosting memory chip demand from firms like Samsung.

Topics

Unlocking the Power of Intel Core Series 2: A Comprehensive Guide to Edge AI Solutions

Intel unveils Core Processor Series 2 and AI suite for healthcare, enhancing edge computing performance and reliability in industrial settings.

Samsung’s Record R&D Investment: How it is Shaping the Future of AI and Semiconductors

Samsung Electronics invested a record $25.33 billion in R&D to lead in AI and semiconductors, boosting its future tech capabilities.

How Rising Fuel Prices Impact Asian Airlines: A Comparison of FSC vs. LCC

Low-cost carriers are struggling to cope with rising fuel prices, lacking effective hedging strategies unlike major airlines.

SK Group Invests 630 Million USD AI Company

SK Group invests heavily in AI, aiming to transform into a leader in the AI market through a new U.S. investment firm.

Nvidia’s Jensen Huang Predicts 1000x Surge in AI Computing Demand

Nvidia's CEO highlights surging AI computing demand due to AI agents like OpenClaw, boosting memory chip demand from firms like Samsung.

How Samsung’s Galaxy S26 Series Leverages India’s R&D for Innovation

Samsung's R&D centers in India are key to developing the Galaxy S26, highlighting India's role in global tech innovation.

GPT-5.4 vs. GPT-5.2: What Makes OpenAI’s Latest Model a Game Changer?

OpenAI launched GPT-5.4, an AI model enhancing professional tasks with improved coding, reasoning, and tool integration capabilities.

Apple MacBook Air M5: Is the Price Increase Worth the AI Performance Boost?

Apple launches the MacBook Air with M5 chip, doubling storage and enhancing AI capabilities, starting from 1,223 USD.

Related Articles